fibrinogen has been researched along with Hematologic Malignancies in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Hee, HI; Khoo, CEH; Long, MH; Shi, L | 1 |
| Ashizawa, M; Fujiwara, SI; Hatano, K; Hayakawa, J; Ikeda, T; Ishihara, Y; Ito, S; Kanda, Y; Kawaguchi, SI; Kawasaki, Y; Mashima, K; Minakata, D; Morita, K; Muroi, K; Nagayama, T; Nakano, H; Nakasone, H; Ochi, SI; Oh, I; Ohmine, K; Ohmori, T; Sato, K; Sugimoto, M; Toda, Y; Umino, K; Yamamoto, C; Yamasaki, R | 1 |
| Liu, P; Niu, T; Wang, M; Wei, Q; Yang, J; Yi, Y | 1 |
| Apelseth, TO; Eide, GE; Hervig, T; Opheim, EN; Stanworth, SJ | 1 |
| Berritta, D; Cupri, A; Fauci, AL; Leotta, S; Milone, G; Parisi, M; Spina, P; Tripepi, G | 1 |
| Fenger-Eriksen, C; Fries, D; Larsen, OH; Munk-Andersen, H; Schenk, B | 1 |
| Chang, YJ; Chen, H; Chen, Y; Chen, YH; Han, W; Huang, XJ; Liu, KY; Mo, XD; Wang, FR; Wang, JZ; Wang, QM; Wang, Y; Xu, LP; Zhang, XH; Zhang, YY | 1 |
| Gabazza, EC; Kushiya, F; Mori, Y; Nishikawa, M; Nobori, T; Okabayashi, K; Shiku, H; Wada, H; Watanabe, M | 1 |
| Bareford, D; Blann, AD; Gurney, D; Lip, GY; Stonelake, P; Wadley, M | 1 |
1 review(s) available for fibrinogen and Hematologic Malignancies
| Article | Year |
|---|---|
CREST: clinical bleeding and risk evaluation in hematology-oncology patients: a systematic review and meta-analysis of thromboelastography's role.
Topics: Fibrinogen; Hematologic Neoplasms; Hematology; Hemorrhage; Humans; Platelet Transfusion; Prospective Studies; Thrombelastography | 2022 |
1 trial(s) available for fibrinogen and Hematologic Malignancies
| Article | Year |
|---|---|
Fibrinogen concentrate improves clot strength in patients with haematological malignancies requiring platelet transfusion.
Topics: Adolescent; Adult; Aged; Blood Coagulation; Female; Fibrinogen; Hematologic Neoplasms; Hemorrhage; Humans; Male; Middle Aged; Platelet Transfusion | 2016 |
7 other study(ies) available for fibrinogen and Hematologic Malignancies
| Article | Year |
|---|---|
Comparison of Danaparoid Sodium and Synthetic Protease Inhibitors for the Treatment of Disseminated Intravascular Coagulation Associated with Hematological Malignancies: A Retrospective Analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Chondroitin Sulfates; Dermatan Sulfate; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematologic Neoplasms; Hemorrhage; Heparitin Sulfate; Humans; Male; Middle Aged; Plasma; Protease Inhibitors; Prothrombin Time; Retrospective Studies; Treatment Outcome | 2020 |
A Revised Fibrinogen Cutoff Value in the Chinese Disseminated Intravascular Coagulation Scoring System May Provide a Better Prognostic Value for Hematological Malignancies.
Topics: Adult; Biomarkers; China; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hematologic Neoplasms; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Reference Values; Retrospective Studies; ROC Curve | 2017 |
Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.
Topics: Adult; Blood Platelets; C-Reactive Protein; Female; Fibrinogen; Hematologic Neoplasms; Hemorrhage; Humans; Male; Pilot Projects; Platelet Count; Platelet Transfusion; Prospective Studies; Risk; Thrombelastography; Thrombocytopenia | 2017 |
Palifermin reduces infection rate and hyperfibrinogenemia in patients treated with high-dose chemotherapy based on beam or BU-thiothepa.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Cytarabine; Female; Fibrinogen; Fibroblast Growth Factor 7; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Male; Melphalan; Middle Aged; Podophyllotoxin; Retrospective Studies; Thiotepa; Transplantation Conditioning; Young Adult | 2014 |
Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Allografts; Anemia, Aplastic; Case-Control Studies; Child; Child, Preschool; Consciousness Disorders; Female; Fibrinogen; Graft vs Host Disease; Hematologic Neoplasms; Hematoma, Subdural; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infections; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Count; Retrospective Studies; Risk Factors; Seizures; Survival Rate; Transplantation Conditioning; Young Adult | 2016 |
High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Topics: Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antithrombin III; Biomarkers; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinolysis; Hematologic Neoplasms; Hemorrhage; Humans; Infections; Interleukin-1; Interleukin-6; International Normalized Ratio; Male; Middle Aged; Multiple Organ Failure; Neoplasms; Peptide Hydrolases; Plasminogen; Plasminogen Activator Inhibitor 1; Platelet Count; Prognosis; Thrombomodulin; Thromboplastin; Thrombosis; Tissue Plasminogen Activator | 2003 |
Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor.
Topics: Adult; Aged; Biomarkers; Breast Neoplasms; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Hematologic Neoplasms; Humans; Male; Middle Aged; P-Selectin; Plasminogen Inactivators; Solubility; von Willebrand Factor | 2001 |